Ajanta Pharma has announced a fresh grant of 1,45,000 stock options under the Ajanta Pharma Share Based Incentive Plan 2019. Alongside this expansion of employee incentives, the company has approved the cancellation of 850 stock options, which have been returned to the ESOP pool. This update reflects the company’s ongoing commitment to its internal incentive framework as of May 5, 2026.
Expansion of Stock Option Program
The Nomination and Remuneration Committee of Ajanta Pharma has formally approved the grant of 1,45,000 stock options. Issued under the company’s 2019 Share Based Incentive Plan, this move is part of the organization’s strategy to align employee interests with long-term company performance. Each of these granted options entitles the holder to one equity share upon successful exercise.
Vesting and Exercise Terms
Under the terms of the newly granted options, participants will be eligible to exercise their rights within a window of three months from the date of vesting. This structured exercise period is designed to provide clarity and maintain operational efficiency within the company’s incentive administration.
Adjustment to ESOP Pool
In addition to the new grants, the company confirmed the cancellation of 850 stock options. These options have been credited back to the ESOP pool, ensuring the available inventory of stock options remains managed in accordance with corporate governance standards and the internal incentive plan guidelines.
Source: BSE
